RiverPark Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,555
Closed -$42K 157
2025
Q2
$42K Sell
1,555
-2,322
-60% -$67.3K 0.03% 120
2025
Q1
$115K Sell
3,877
-880
-18% -$33.5K 0.09% 93
2024
Q4
$188K Sell
4,757
-112
-2% -$4.24K 0.15% 83
2024
Q3
$166K Buy
+4,869
New +$137K 0.14% 87

Other funds holding VCYT

RiverPark Advisors's VCYT Position: Q3 2025 in Review

RiverPark Advisors sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 1,555 shares — an estimated $42K sold.

RiverPark Advisors first reported a position in VCYT in Q3 2024 and held it in 4 quarters. The position peaked at $188K in Q4 2024. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

  • RiverPark Advisors reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
  • RiverPark Advisors sold 1,555 Veracyte shares in Q3 2025, an estimated $42K.
  • RiverPark Advisors first reported a position in Veracyte in Q3 2024 and held it in 4 quarters.
  • RiverPark Advisors's Veracyte position peaked at $188K in Q4 2024.
  • 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on RiverPark Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.